Detall de la convocatòria
Característiques
| Característica |
|---|
|
Objectiu de la convocatòria
This grant program supports Investigator-Sponsored Research (ISR) that addresses knowledge gaps and unmet medical needs related to long-acting growth hormone treatment and follow-up. |
|
Característiques principals
- Evaluate different parameters of long-acting growth hormone treatment vs daily growth hormone, such as clinical effect, adherence and/or pathophysiology, in real world setting. - Explore novel concepts in monitoring and follow-up with daily and long-acting growth hormone treatment. - Explore novel strategies to address current unmet medical needs in short stature management which could be addressed with long-acting growth hormone treatment. - Pfizer will not supply drug for independent research studies. |
|
Lloc de presentació
HMRIB and PSMAR staff who need more information should contact: Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00. Carol Barnwell: [email protected] Ext.: 1670 Marta López: [email protected] Ext.: 1576 Júlia Vidal: [email protected] Ext.: 1736 |
|
Convocatòria (URL)
https://cdn.pfizer.com/pfizercom/2026-02/2026-RD-G-Endocrine-RES.pdf?VersionId=Kq58pAUcZDcqxm5wN3L1h7WPYIunJu0H |
|
Requisits
|
|
Dotació
$50,000 to $75,000 |
|
Durada
1 to 2 years |
Arxius
| Arxiu |
|---|
| 2026-RD-G-Endocrine-RES.pdf |